Viaskin® Peanut Recruiting Participants for Safety Study

Science Rocks!
We have previously blogged about the Viaskin® Peanut patch (see The Patch That Was Promised) and how the previous phases of the clinical trial have offered those of us affected by peanut allergies some hope. According to, a safety study is currently recruiting children to be study participants at 32 study locations in the United States and Canada. They need children between 4 and 11 years of age where they will either receive the patch for six months or a placebo. After that time, all participants will receive the active treatment for a period up to three years. More information is available by clicking the link below.

Safety Study of Viaskin Peanut to Treat Peanut Allergy (REALISE)

From the website:


Ages Eligible for Study: 4 Years to 11 Years (Child)
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Inclusion Criteria:

  • Physician-diagnosed peanut allergy;

  • A peanut Skin Prick Test (SPT) with a wheal largest diameter ≥8 mm;

  • A specific-peanut Immunoglobulin E (IgE) ≥14 kU/L;

  • Subjects following a strict peanut-free diet.

Image from Flickr user Glenn Strong. Creative Common License